MICROLIFE WatchBP Home A (Professional use) + SOFTWARE 

- detection of atrial fibrillation (specific heart arrhythmia) 

- embedded ESH/AHA measurement guidelines lead to accurate home measurement data physician can trust in 

- automated data tabulations displays averages for morning, evening and overall measurement 

- clinically tested (BHS protocol) 

- MAM technology (automatic analysis of 3 consecutive measurements)

- 250 Data memory in «USUAL» mode 

- USB port and mains adapter port 

- low battery indication 

- 4x1.5 V AA batteries 

Supplied with carrying bag, USB cable, soft cuff 22-32 cm, software (GB) and manual (GB, IT, FR, DE). Other languages available from web (ES, DK, GR, FI, NL, NO, RU, SE, UA). 

Extra large display 

Size: 150 x 100 x 50 mm 

Weight: 385 g

Technical Specifications 

MICROLIFE AFIB technology: 

An innovative and patented technology for the early detection of Atrial fibrillation (AF). 

More than 30,000 fatal strokes can be prevented within the European Union by using Microlife AFIB Technology in primary care. 

The new Microlife AFIB technology allows simultaneous blood pressure measurement and AF screening. Microlife AFIB technology detects AF with high sensitivity (97-100%) and specificity (89%) as demonstrated in several clinical studies. 

Nice guidelines for “Diagnosis and assessment of hypertension” recommended to use AFIB screening for routine blood pressure measurement in primary care. AF screening by using a Microlife AFIB device is highly recommended in patients that have to monitor their blood pressure while at home.